重組蛋白質的全球市場:各產品，用途，終端用戶，地區的市場規模調查與預測(2022～2028年)

全球重組蛋白質的市場規模，2021年約9億1,000萬美金，在2022～2028年的預測期間中預計以9.8％以上的健全成長率成長。

本報告提供全球重組蛋白質市場相關調查分析，產業分析，COVID-19影響分析，各用途、終端用戶、地區市場分析，競爭情形相關資訊。

目錄

第1章 摘要整理

第2章 全球重組蛋白質市場定義和範圍

第3章 全球重組蛋白質的市場動態

• 重組蛋白質市場影響分析(2020～2028年)

第4章 全球重組蛋白質市場產業分析

• 波特的五力分析
• PEST分析
• 投資採用模式
• 分析師的推薦事項與結論
• 主要投資機會
• 主要制勝策略

第5章 風險評估:COVID-19影響

• COVID-19對產業的整體影響的評估
• COVID-19前及COVID-19後的市場情境

第6章 全球重組蛋白質市場:各產品

• 市場概述
• 全球重組蛋白質市場的潛力分析:各產品、效能
• 全球重組蛋白質市場估計與預測:各產品(2019～2028年(100萬美元))
• 重組蛋白質市場:子區隔分析
  • 抗體
  • 荷爾蒙
  • 成長要素
  • 酵素
  • 細胞激素
  • 其他

第7章 全球重組蛋白質市場:各用途

• 市場概述
• 全球重組蛋白質市場的潛力分析:各用途、效能
• 全球重組蛋白質市場估計與預測:各用途(2019～2028年(100萬美元))
• 重組蛋白質市場:子區隔分析
  • 藥物研發、開發
  • 生物製藥的生產
  • 生物科技研究
  • 學術研究
  • 其他的用途

第8章 全球重組蛋白質市場:各終端用戶

• 市場概述
• 全球重組蛋白質市場的潛力分析:各終端用戶、效能
• 全球重組蛋白質市場估計與預測:各終端用戶(2019～2028年(100萬美元))
• 重組蛋白質市場:子區隔分析
  • 製藥及生物製藥企業
  • 生物科技企業
  • 學術研究機關
  • 受託研究機構
  • 其他的終端用戶

第9章 全球重組蛋白質市場:地區分析

• 各地區市場的概述
• 北美
  • 美國
  • 加拿大
• 歐洲概述
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 義大利
  • 其他歐洲
• 亞太地區概述
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 其他亞太地區
• 南美概述
  • 巴西
  • 墨西哥
• 其他地區

第10章 競爭資訊

• 主要市場策略
• 企業簡介
  • Thermo Fisher Scientific, Inc.
  • Miltenyi Biotech
  • Sino Biological Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzo Life Sciences, Inc.
  • BPS Bioscience, Inc.
  • Stemcell Technologies Inc
  • RayBiotech Inc
  • Richcore Lifesciences Pvt Ltd
  • United States Biological

第11章 調查流程

Global Recombinant Proteins Market is valued approximately USD 910 million in 2021 and is anticipated to grow with a healthy growth rate of more than 9.8% over the forecast period 2022-2028.

Recombinant proteins are the new amalgamation of genes that are primarily used to generate DNA. Recombinant DNA technology helps in the production of wild-type and modified human, mammalian proteins in bulk quantities. Recombinant protein formation needs a special method known as recombinant DNA (rDNA) technology. This protein is used for the development of new therapies for severe chronic diseases like cancer and other rare diseases. The increasing government funding and rising investment for R&D activities in pharmaceutical & biotechnology companies, and increasing incidences of chronic & infectious diseases are the primary factors that may augment the market demand across the globe. In addition, rising inclination toward biologics and biosimilars, technological developments in recombinant products, coupled with the increasing collaborations of the industry-academia are further chief driving factors for the market growth in the approaching years. For instance, in 2019, Thermo Fisher Scientific, Inc. collaborated with the Biopharmaceutical Analysis Training Laboratory (BATL) of Northeastern University. The aim of this collaboration is to develop analytical capabilities and to introduce novel innovations in the biopharmaceutical industry especially in applications like monoclonal antibodies, personalized medicine, and gene & cell therapies. Similarly, in 2020, Bio-Techne Corporation partnered with Elpiscience BioPharma with the objective of advancing anticancer therapeutics. This allows Elpiscience to access over Bio-Techne's antibodies portfolio for developing the company's preclinical, clinical, and commercial biopharmaceuticals. However, expensive and time-consuming production processes and safety concerns associated with recombinant proteins impede the growth of the market over the forecast period of 2022-2028. Also, the growing focus on personalized medicine and protein therapeutics and increasing expenditure on research and development activities are anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Recombinant Proteins Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the availability of favorable government funding and the increasing presence of major companies across the region. Whereas, Asia-Pacific is also anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as growing incidences of chronic & infectious diseases, as well as increasing spending on the R&D activities, would create lucrative growth prospects for the Recombinant Proteins Market across the Asia-Pacific region.

Major market players included in this report are:

Thermo Fisher Scientific, Inc.

Miltenyi Biotech

Sino Biological Inc.

Bio-Rad Laboratories, Inc.

Enzo Life Sciences, Inc.

BPS Bioscience, Inc.

Stemcell Technologies Inc

RayBiotech Inc

Richcore Lifesciences Pvt Ltd

United States Biological

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product

Antibodies

Hormones

Growth Factors

Enzyme

Cytokines

Others

By Application

Drug Discovery & Development

Biopharmaceutical Production

Biotechnology Research

Academic Research Studies

Other Applications

By End User

Pharmaceutical & Biopharmaceutical Companies

Biotechnology Companies

Academic Research Institutes

Contract Research Organizations

Other End Users

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Recombinant Proteins Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
  • 1.2.1. Global Recombinant Proteins Market, by Region, 2020-2028 (USD Million)
  • 1.2.2. Global Recombinant Proteins Market, by Product, 2020-2028 (USD Million)
  • 1.2.3. Global Recombinant Proteins Market, by Application, 2020-2028 (USD Million)
  • 1.2.4. Global Recombinant Proteins Market, by End User, 2020-2028 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Recombinant Proteins Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Recombinant Proteins Market Dynamics

• 3.1. Recombinant Proteins Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising inclination toward biologics and biosimilars
    • 3.1.1.2. Increasing prevalence of chronic & infectious diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. Expensive and time-consuming production process
    • 3.1.2.2. Safety concern associated with recombinant proteins
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing focus on personalized medicine and protein therapeutics
    • 3.1.3.2. Increasing expenditure on research and development activities

Chapter 4. Global Recombinant Proteins Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Recombinant Proteins Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Recombinant Proteins Market by Product, Performance - Potential Analysis
• 6.3. Global Recombinant Proteins Market Estimates & Forecasts by Product 2019-2028 (USD Million)
• 6.4. Recombinant Proteins Market, Sub Segment Analysis
  • 6.4.1. Antibodies
  • 6.4.2. Hormones
  • 6.4.3. Growth Factors
  • 6.4.4. Enzyme
  • 6.4.5. Cytokines
  • 6.4.6. Others

Chapter 7. Global Recombinant Proteins Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Recombinant Proteins Market by Application, Performance - Potential Analysis
• 7.3. Global Recombinant Proteins Market Estimates & Forecasts by Application 2019-2028 (USD Million)
• 7.4. Recombinant Proteins Market, Sub Segment Analysis
  • 7.4.1. Drug Discovery & Development
  • 7.4.2. Biopharmaceutical Production
  • 7.4.3. Biotechnology Research
  • 7.4.4. Academic Research Studies
  • 7.4.5. Other Applications

Chapter 8. Global Recombinant Proteins Market, by End User

• 8.1. Market Snapshot
• 8.2. Global Recombinant Proteins Market by End User, Performance - Potential Analysis
• 8.3. Global Recombinant Proteins Market Estimates & Forecasts by End User 2019-2028 (USD Million)
• 8.4. Recombinant Proteins Market, Sub Segment Analysis
  • 8.4.1. Pharmaceutical & Biopharmaceutical Companies
  • 8.4.2. Biotechnology Companies
  • 8.4.3. Academic Research Institutes
  • 8.4.4. Contract Research Organizations
  • 8.4.5. Other End Users

Chapter 9. Global Recombinant Proteins Market, Regional Analysis

• 9.1. Recombinant Proteins Market, Regional Market Snapshot
• 9.2. North America Recombinant Proteins Market
  • 9.2.1. U.S. Recombinant Proteins Market
    • 9.2.1.1. Product estimates & forecasts, 2019-2028
    • 9.2.1.2. Application estimates & forecasts, 2019-2028
    • 9.2.1.3. End User estimates & forecasts, 2019-2028
  • 9.2.2. Canada Recombinant Proteins Market
• 9.3. Europe Recombinant Proteins Market Snapshot
  • 9.3.1. U.K. Recombinant Proteins Market
  • 9.3.2. Germany Recombinant Proteins Market
  • 9.3.3. France Recombinant Proteins Market
  • 9.3.4. Spain Recombinant Proteins Market
  • 9.3.5. Italy Recombinant Proteins Market
  • 9.3.6. Rest of Europe Recombinant Proteins Market
• 9.4. Asia-Pacific Recombinant Proteins Market Snapshot
  • 9.4.1. China Recombinant Proteins Market
  • 9.4.2. India Recombinant Proteins Market
  • 9.4.3. Japan Recombinant Proteins Market
  • 9.4.4. Australia Recombinant Proteins Market
  • 9.4.5. South Korea Recombinant Proteins Market
  • 9.4.6. Rest of Asia Pacific Recombinant Proteins Market
• 9.5. Latin America Recombinant Proteins Market Snapshot
  • 9.5.1. Brazil Recombinant Proteins Market
  • 9.5.2. Mexico Recombinant Proteins Market
• 9.6. Rest of The World Recombinant Proteins Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Thermo Fisher Scientific, Inc.
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Miltenyi Biotech
  • 10.2.3. Sino Biological Inc.
  • 10.2.4. Bio-Rad Laboratories, Inc.
  • 10.2.5. Enzo Life Sciences, Inc.
  • 10.2.6. BPS Bioscience, Inc.
  • 10.2.7. Stemcell Technologies Inc
  • 10.2.8. RayBiotech Inc
  • 10.2.9. Richcore Lifesciences Pvt Ltd
  • 10.2.10. United States Biological

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Recombinant Proteins Market, report scope
• TABLE 2. Global Recombinant Proteins Market estimates & forecasts by Region 2019-2028 (USD Million)
• TABLE 3. Global Recombinant Proteins Market estimates & forecasts by Product 2019-2028 (USD Million)
• TABLE 4. Global Recombinant Proteins Market estimates & forecasts by Application 2019-2028 (USD Million)
• TABLE 5. Global Recombinant Proteins Market estimates & forecasts by End User 2019-2028 (USD Million)
• TABLE 6. Global Recombinant Proteins Market by segment, estimates & forecasts, 2019-2028 (USD Million)
• TABLE 7. Global Recombinant Proteins Market by region, estimates & forecasts, 2019-2028 (USD Million)
• TABLE 8. Global Recombinant Proteins Market by segment, estimates & forecasts, 2019-2028 (USD Million)
• TABLE 9. Global Recombinant Proteins Market by region, estimates & forecasts, 2019-2028 (USD Million)
• TABLE 10. Global Recombinant Proteins Market by segment, estimates & forecasts, 2019-2028 (USD Million)
• TABLE 11. Global Recombinant Proteins Market by region, estimates & forecasts, 2019-2028 (USD Million)
• TABLE 12. Global Recombinant Proteins Market by segment, estimates & forecasts, 2019-2028 (USD Million)
• TABLE 13. Global Recombinant Proteins Market by region, estimates & forecasts, 2019-2028 (USD Million)
• TABLE 14. Global Recombinant Proteins Market by segment, estimates & forecasts, 2019-2028 (USD Million)
• TABLE 15. Global Recombinant Proteins Market by region, estimates & forecasts, 2019-2028 (USD Million)
• TABLE 16. U.S. Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 17. U.S. Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 18. U.S. Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 19. Canada Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 20. Canada Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 21. Canada Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 22. UK Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 23. UK Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 24. UK Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 25. Germany Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 26. Germany Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 27. Germany Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 28. RoE Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 29. RoE Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 30. RoE Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 31. China Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 32. China Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 33. China Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 34. India Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 35. India Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 36. India Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 37. Japan Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 38. Japan Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 39. Japan Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 40. RoAPAC Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 41. RoAPAC Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 42. RoAPAC Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 43. Brazil Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 44. Brazil Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 45. Brazil Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 46. Mexico Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 47. Mexico Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 48. Mexico Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 49. RoLA Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 50. RoLA Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 51. RoLA Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 52. Row Recombinant Proteins Market estimates & forecasts, 2019-2028 (USD Million)
• TABLE 53. Row Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 54. Row Recombinant Proteins Market estimates & forecasts by segment 2019-2028 (USD Million)
• TABLE 55. List of secondary sources, used in the study of global Recombinant Proteins Market
• TABLE 56. List of primary sources, used in the study of global Recombinant Proteins Market
• TABLE 57. Years considered for the study
• TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Recombinant Proteins Market, research methodology
• FIG 2. Global Recombinant Proteins Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Recombinant Proteins Market, key trends 2021
• FIG 5. Global Recombinant Proteins Market, growth prospects 2022-2028
• FIG 6. Global Recombinant Proteins Market, porters 5 force model
• FIG 7. Global Recombinant Proteins Market, pest analysis
• FIG 8. Global Recombinant Proteins Market, value chain analysis
• FIG 9. Global Recombinant Proteins Market by segment, 2019 & 2028 (USD Million)
• FIG 10. Global Recombinant Proteins Market by segment, 2019 & 2028 (USD Million)
• FIG 11. Global Recombinant Proteins Market by segment, 2019 & 2028 (USD Million)
• FIG 12. Global Recombinant Proteins Market by segment, 2019 & 2028 (USD Million)
• FIG 13. Global Recombinant Proteins Market by segment, 2019 & 2028 (USD Million)
• FIG 14. Global Recombinant Proteins Market, regional snapshot 2019 & 2028
• FIG 15. North America Recombinant Proteins Market 2019 & 2028 (USD Million)
• FIG 16. Europe Recombinant Proteins Market 2019 & 2028 (USD Million)
• FIG 17. Asia pacific Market 2019 & 2028 (USD Million)
• FIG 18. Latin America Recombinant Proteins Market 2019 & 2028 (USD Million)
• FIG 19. Global Recombinant Proteins Market, company Market share analysis (2021)